Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging.

An interesting aside was the observation of a significant trend (p = 0.013) to increase in fluorescence values at 0 minutes in oxaliplatin treated animals ( Table 2 , first column) as the study progresses, suggesting that some of the imaging agent does not clear out between imaging sessions, but persists in the animals to elevate the baseline.

also in 6,185 other papers